As of 2026-04-06, the EV/EBITDA ratio of Moberg Pharma AB (publ) (MOB.ST) is -11.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOB.ST's latest enterprise value is 283.05 mil SEK. MOB.ST's TTM EBITDA according to its financial statements is -25.71 mil SEK. Dividing these 2 quantities gives us the above MOB.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 3.2x - 4.8x | 4.2x |
| Forward P/E multiples | 5.1x - 5.7x | 5.3x |
| Fair Price | 1.98 - 2.18 | 2.18 |
| Upside | -81.2% - -79.3% | -79.2% |
| Date | EV/EBITDA |
| 2026-04-02 | -10.93 |
| 2026-04-01 | -10.82 |
| 2026-03-31 | -10.67 |
| 2026-03-30 | -10.56 |
| 2026-03-27 | -10.14 |
| 2026-03-26 | -10.56 |
| 2026-03-25 | -9.97 |
| 2026-03-24 | -10.12 |
| 2026-03-23 | -10.92 |
| 2026-03-20 | -11.01 |
| 2026-03-19 | -11.01 |
| 2026-03-18 | -12.47 |
| 2026-03-17 | -12.96 |
| 2026-03-16 | -13.00 |
| 2026-03-13 | -13.00 |
| 2026-03-12 | -11.96 |
| 2026-03-11 | -11.22 |
| 2026-03-10 | -11.24 |
| 2026-03-09 | -10.40 |
| 2026-03-06 | -10.76 |
| 2026-03-05 | -10.54 |
| 2026-03-04 | -10.90 |
| 2026-03-03 | -10.08 |
| 2026-03-02 | -10.06 |
| 2026-02-27 | -10.73 |
| 2026-02-26 | -10.12 |
| 2026-02-25 | -9.97 |
| 2026-02-24 | -10.10 |
| 2026-02-23 | -10.12 |
| 2026-02-20 | -8.92 |
| 2026-02-19 | -8.80 |
| 2026-02-18 | -8.19 |
| 2026-02-17 | -8.39 |
| 2026-02-16 | -8.45 |
| 2026-02-13 | -8.49 |
| 2026-02-12 | -8.43 |
| 2026-02-11 | -8.72 |
| 2026-02-10 | -9.08 |
| 2026-02-09 | -8.88 |
| 2026-02-06 | -8.46 |
| 2026-02-05 | -8.40 |
| 2026-02-04 | -8.73 |
| 2026-02-03 | -9.07 |
| 2026-02-02 | -8.98 |
| 2026-01-30 | -9.02 |
| 2026-01-29 | -8.66 |
| 2026-01-28 | -8.96 |
| 2026-01-27 | -8.77 |
| 2026-01-26 | -8.96 |
| 2026-01-23 | -9.00 |